Combacte-Magnet

EPI-Net

Newsletter

Issue no. 7, June 2020

Sharing exciting project news and updates!

 

Ensuring continuity in AMR research in the face of COVID

 

COVID-19 pandemic has unleashed an unprecedented toll on humanity, not only on people’s health, but also on everyday life and the generally perceived normality. Through solidarity, the medical and scientific communities have risen together to battle the virus. In times like these, sustaining all other research activities is only possible by working together even closer to overcome the structural challenges the pandemic has caused.

Read more

AMR Blind spots: strengthening disease surveillance in regional Australia

 

Although Australia is recognised as having high-quality healthcare and the overall rate of antimicrobial resistance (AMR) is low, people living in regional areas continue to experience worse health outcomes and higher rates of AMR. Dr Teresa Wozniak and her team are committed to reducing this gap.

 
Read more

C. difficile infections: understanding epidemiology and impact

Latest results from our partners, the COMBACTE CDI consortium, on the burden and current diagnosis and treatment practises of CDI in Europe are now available online

 
Read more

White papers: “Bridge the gap: survey to treat”

A framework that provides a set of target actions for linking surveillance data with AMS activities in human and animal sectors has been finalized as part of the collaborations between the COMBACTE MAGNET EPI-Net and JPMIAR ARCH networks.

 
Read more

EPI-Net receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n°115737, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

This email was created with Wix.‌ Discover More